Is Low LDL Bad For The Epigenetic Pace of Aging?

Conquer Aging Or Die Trying!
25 Feb 202412:13

Summary

TLDRThe speaker analyzes correlations between his diet, biomarkers, and epigenetic pace of aging over 12 tests. No foods or nutrients significantly correlate with pace of aging, but DHEA sulfate and LDL cholesterol do, suggesting higher levels correlate with slower aging. The speaker plans to increase LDL levels slightly through more coconut butter to test if it further slows his aging pace, while aiming to remain in the safe range for heart disease risk.

Takeaways

  • πŸ˜€ The transcript discusses analyzing data on epigenetic pace of aging (DN Pace) to try to slow it down
  • πŸ§ͺ There were no foods or nutrients significantly correlated with DN Pace, so biomarker correlations were analyzed
  • πŸ’‰ Four biomarkers were significantly correlated: liver enzymes, platelets and inversely DHEA sulfate and LDL
  • πŸ“ˆ Higher DHEA sulfate was correlated with slower epigenetic aging pace
  • ⬇️ Lower LDL was correlated with faster epigenetic aging pace
  • ❀️ Moderate LDL levels of 65-120 mg/dL had lowest heart disease mortality risk
  • πŸ˜• Very low LDL (<65) or high LDL (>120) increased heart disease mortality risk
  • πŸ₯₯ Saturated fats like coconut oil can increase LDL levels moderately
  • πŸ“… The goal is to safely raise LDL slightly above 85 mg/dL for the next test on March 4, 2024
  • πŸ‘ If successful, this could help validate the correlation between higher LDL and slower epigenetic aging

Q & A

  • What metric is the speaker using to measure epigenetic pace of aging?

    -The speaker is using DNA methylation age (DNAm age) and DNA methylation pace (DNAm pace) to measure epigenetic pace of aging.

  • What is the goal of tracking correlations between biomarkers and diet?

    -The goal is to find dietary factors that are significantly correlated (p < 0.05) with DNAm age and pace in order to follow those correlations to try to improve the biomarkers.

  • Which nutrient had the strongest correlation with DNAm age and pace?

    -Vitamin B6 had the strongest correlation with a p-value of 0.1, but no foods or nutrients met the threshold for statistical significance (p < 0.05).

  • What biomarker had a significant inverse correlation with DNAm age and pace?

    -DHEA sulfate had a significant inverse correlation, meaning higher levels were associated with slower epigenetic aging.

  • How could lowering LDL too much negatively impact health?

    -The data suggests very low LDL (< 65 mg/dL) is associated with higher risk of heart disease mortality. Lowering LDL too aggressively could potentially negatively impact heart health.

  • What is the safe target range for LDL based on the presented data?

    -The data suggests an LDL range of 65-120 mg/dL is associated with lowest risk for heart disease mortality.

  • What dietary change did the speaker make to try to increase LDL levels?

    -The speaker increased intake of coconut butter to increase saturated fat intake, as saturated fats are correlated with higher LDL levels.

  • How many data points did the speaker have relating DNAm metrics to other biomarkers?

    -The speaker had 9-11 data points relating DNAm age/pace to the other 23 blood biomarkers analyzed.

  • What technique does the speaker use to precisely track dietary intake?

    -The speaker uses a food scale to weigh all food, tracks intake in Chronometer, and logs averages over 60 day periods leading up to each blood test.

  • When is the next DNAm age and pace test scheduled?

    -The next test is scheduled for March 4, 2024, with results expected in April.

Outlines

00:00

🧬 Author analyzes biomarkers correlated with epigenetic pace of aging

The author explains that he tracked his diet and biomarkers over time to analyze correlations. No foods/nutrients were significantly correlated with epigenetic pace. Analyzing other biomarkers revealed LDL, DHEA sulfate, liver enzymes, and platelets were significantly correlated. The author will try raising LDL slightly to test if it improves epigenetic pace while remaining in the safe range for heart disease mortality risk.

05:02

πŸ‘΄ Lower LDL correlated with faster epigenetic aging pace for author

The data shows a significant inverse correlation between the author's LDL levels and his epigenetic pace of aging. In other words, lower LDL levels correlate with faster epigenetic aging pace. One data point with very low LDL (65 mg/dL) corresponded to his fastest epigenetic aging pace.

10:03

πŸ“ˆ Author aims to safely increase LDL to test correlation

There is a safe LDL range of 65-120 mg/dL associated with lowest heart disease mortality risk based on a large study. To test if higher LDL correlates with slower epigenetic aging pace for him, the author aims to safely raise his LDL from 62-83 mg/dL to 90-95 mg/dL by increasing saturated fat intake from coconut butter.

Mindmap

Keywords

πŸ’‘epigenetic pace of aging

This refers to the rate at which a person's epigenome changes over time. The video discusses measuring the epigenetic pace of aging using DNA methylation data. A slower pace means the epigenome is changing more slowly, suggesting slower biological aging.

πŸ’‘DNA methylation

DNA methylation is an epigenetic mechanism that regulates gene expression. The level of DNA methylation at specific sites on genes can be used to estimate biological age and the epigenetic pace of aging.

πŸ’‘biomarkers

Biomarkers are measurable indicators of biological processes or disease state. The video analyzes correlations between the epigenetic pace of aging and various other biomarkers like LDL, platelets, etc.

πŸ’‘LDL cholesterol

LDL (low-density lipoprotein) is considered bad cholesterol, but the video found higher LDL levels correlated with slower epigenetic aging pace. However, very high or very low LDL increased heart disease mortality risk.

πŸ’‘DHEA sulfate

Dehydroepiandrosterone (DHEA) sulfate is a hormone that declines with age. The video's data shows significantly higher DHEA sulfate correlates with slower epigenetic aging.

πŸ’‘nicotinic acid

Nicotinic acid (niacin) is a B vitamin. The video hypothesizes that high-dose nicotinic acid supplementation may have increased NAD+ to high levels, negatively impacting epigenetic aging pace.

πŸ’‘biological aging

Biological aging refers to the time-dependent biological changes that accumulate overtime, causing gradual decrease in an organism's ability to resist stress and damage. The video discusses measuring and trying to slow down biological aging.

πŸ’‘aging

Aging is the process of becoming older. It involves molecular and cellular changes overtime throughout the body leading to an increased risk of disease. The video is about measuring biological aging and attempting to slow it down.

πŸ’‘longevity

Longevity refers to how long people live on average or maximum lifespan. The video discusses techniques for measuring biological aging with the ultimate goal of increasing healthy longevity.

πŸ’‘biohacking

Biohacking refers to biological experimentation done by individuals outside of professional science. The video discusses the author's self-experiments in measuring biomarkers, testing diets and supplements for anti-aging effects.

Highlights

I have 12 tests currently done for DHEAA and Pace to track epigenetic aging

No foods or nutrients significantly correlated with DHEAA and Pace

Looked at correlations between DHEAA/Pace and 23 other biomarkers

Higher DHEA sulfate significantly correlated with slower epigenetic aging pace

Higher LDL significantly correlated with slower epigenetic aging pace

Lower LDL correlated with faster epigenetic aging pace

Increasing LDL may improve epigenetic aging pace without increasing heart disease risk

Safe LDL range is 65-120 mg/dL for lowest heart disease mortality risk

Increased coconut butter intake to raise LDL for next test

Next blood test scheduled for March 4, 2024 to validate correlation

Detailed correlation data available on Patreon

Discounts available for epigenetic testing, blood testing, diet tracking

Attempting to biohack aging through testing correlations

Significant correlations guide interventions to improve biomarkers

Following correlations to conquer aging or die trying

Transcripts

play00:00

who has the slowest epigenetic pace of

play00:02

Aging we can see that data here this is

play00:05

the top 15 for the Rejuvenation Olympics

play00:08

and if you notice I'm not on the list so

play00:11

with that in mind what's my data so I

play00:13

have 12 tests currently for done and

play00:16

pace and to get on this test to get on

play00:18

the leaderboard you need an average of

play00:20

three done and Pace measurements over 6

play00:22

months so my last test was in January of

play00:25

2024 6 months prior would be June of

play00:28

2023 now I don't have three tests over

play00:31

that time span I have six tests so I

play00:33

don't know how they'll rank that but I

play00:35

think what makes the most sense is

play00:37

taking the average over that 6-month

play00:39

period which in my case is

play00:41

0.81 0.81 would put me at 14th Place

play00:45

which isn't bad but the goal is

play00:48

obviously to move up now there is hope

play00:51

for optimism as two of those six tests

play00:53

two of the most recent six tests were

play00:55

relatively lower 75 and 74 which would

play00:59

put me into a tie for eighth place so in

play01:01

order to more consistently see my best

play01:04

data I need to know which factors are

play01:06

significantly correlated with the and

play01:08

pace so let's start off with

play01:10

correlations for diet with the and pace

play01:12

and for those who are unfamiliar with

play01:14

the approach since 2015 I weighed all my

play01:17

food using a food scale I then entered

play01:20

those daily food amounts into

play01:22

chronometer and if you want to track

play01:23

your own diet there's a discount link

play01:24

for chronometer in the video's

play01:26

description and then I manually log that

play01:28

data into a spreadsheet so then each

play01:31

blood test has a corresponding average

play01:33

dietary intake in other words for a

play01:35

given 60-day period in between blood

play01:37

tests because I'm tracking diet every

play01:39

day I can take the 60-day average which

play01:42

then lines up with the latter blood test

play01:44

so every blood test has a corresponding

play01:46

average dietary intake and then with

play01:48

many blood tests and many dietary

play01:51

intakes that correspond I can calculate

play01:53

correlations and after calculating

play01:55

correlations with the goal of improving

play01:58

uh biomarkers I I follow or I try to

play02:01

follow as many of the significant

play02:02

correlations as possible with a p Val uh

play02:05

P value less than 0.05 being the measure

play02:07

of statistical significance all right so

play02:10

with that in mind I then looked at 97

play02:12

comparisons for den and past with Foods

play02:15

macro and micronutrients and this is a

play02:17

12 test analysis and we can see the D

play02:21

that data for what data is closest to

play02:24

the being significantly associated with

play02:25

daita Pace here so on the left we've got

play02:28

the food or nutrient and in the middle

play02:30

we've got the correlation and then on

play02:31

the right we've got the P value and

play02:34

notice though that there are no Foods or

play02:36

nutrients that are significantly

play02:38

correlated at a P value less than 0.05

play02:40

with DED and Pace as the best hit the

play02:43

best correlation is vitamin B6 with a P

play02:45

value of 0.1 which is outside of

play02:48

significance so at this point I have two

play02:50

options one just keep testing and gather

play02:53

more data and I'm going to do that

play02:54

anyway so that's not really an option or

play02:56

two I decided to take a deeper dive and

play02:58

this isn't the first time I've done this

play02:59

this I've done biomarker versus

play03:01

biomarker analyses before but in order

play03:03

to get potentially gain more insight

play03:05

into mechanisms that may impact Don need

play03:07

and Pace I then decided to look at

play03:09

correlations for D and Pace with other

play03:11

biomarkers and we can see that full list

play03:13

here correlations for D and Pace with

play03:16

other biomarkers more specifically 23

play03:18

biomarkers that I commonly track as

play03:21

shown here with the full list on the

play03:23

left and then I on the same day as done

play03:25

and pay testing I also measured other

play03:28

bio biomarkers versus ven venopuncture

play03:30

so going to the lab and having them pull

play03:33

it pull it out of my vein and then when

play03:34

I got home I did the uh blood test

play03:36

finger prick for done and pace so I have

play03:39

9 to 11 tests that correspond for

play03:42

standard Blood biomarkers on the same

play03:44

day of testing as D and Pace almost all

play03:46

of the tests as you can see with the N

play03:48

which is the number of samples almost

play03:50

all of them are 11 so 11 tests that

play03:53

match up with the KN and Pace with the

play03:54

exception of DHEA sulfate which I

play03:56

currently have nine data points that

play03:58

overlap and then aging a where I have 10

play04:00

but aging. a has been unfortunately

play04:02

discontinued so that'll always be 10

play04:04

unless that's uh restored and then again

play04:07

in the middle we've got the correlation

play04:09

and then the P value so now we've got

play04:11

four of these biomarkers that are

play04:13

significantly correlated with Don and

play04:14

Pace the liver enzymes a plus alt

play04:18

platelets but then where the story

play04:20

starts to get interesting at least for

play04:21

me is DHEA sulfate which is

play04:24

significantly inversely correlated with

play04:26

Don and paast in other words a

play04:28

relatively higher D DHE sulfate in my

play04:30

data is significally correlated with a

play04:32

slower epigenetic pace of aging and why

play04:35

that's interesting is because my DHEA

play04:37

sulfate is currently one of the

play04:39

weaknesses in my data it's close to age

play04:41

expected and not youthful I've had

play04:43

values that are um about 2 and a half

play04:46

times higher in my early 30s and I just

play04:49

didn't track it for a very long time and

play04:50

they declined over the past uh 15 years

play04:53

or so so getting them back to you for

play04:55

levels without supplementation is a part

play04:57

of the one of the current goals but then

play04:59

where the story gets most interesting at

play05:01

least for me is LDL and there too is a

play05:05

significant inverse correlation so let's

play05:06

take a deeper look at that

play05:09

correlation so it's 11 tests for Don and

play05:12

Pace versus LDL and then we can see with

play05:14

Donita Pace on the y- axis plotted

play05:16

against the LDL concentration on the X

play05:18

we can see that significant inverse

play05:20

correlation for LDL against D Pace in

play05:23

other words relatively higher LDL in my

play05:26

data is significantly correlated with a

play05:28

slower epen pace of Aging conversely

play05:31

lower LDL is significant correlated with

play05:34

a faster epigenetic pace of Aging but

play05:36

note that these data just to highlight

play05:38

the range in my case at this current uh

play05:41

point in time is from 62 to 83 Mig per

play05:45

deciliter I I'm not trying to make any

play05:47

extrapolations for people who have LDL

play05:49

far higher that's a story for a

play05:51

different day now also note that for one

play05:54

of these tests highd do nicotinic acid

play05:57

uh on this on the where I had a 0.98

play05:59

which which is my worst Donan Pace yet

play06:01

to date LDL on that date was 65 now in

play06:06

earlier videos I've hypothesized that

play06:08

highd dose nasin 600 milligrams per day

play06:11

May raise Ned too high and that may have

play06:14

been what messed up Don pce sending it

play06:16

to my worst value to date but these data

play06:18

would suggest that maybe going uh maybe

play06:22

highd do nasin nicotinic acid reduces

play06:24

LDL to a level where it may be too low

play06:27

negatively impacting epigenetic pace of

play06:31

Aging so note that there are only two

play06:33

data points on the far left side of 65

play06:36

mg per decer so there is some

play06:38

extrapolation on this graph so instead

play06:40

of testing that hypothesis by reducing

play06:43

my LDL as low as it can go and seeing if

play06:45

my the need and Pace gets even worse

play06:47

conversely I think testing the other

play06:49

side of that curve or the other side of

play06:51

that that uh

play06:53

slope in other words if I increase LDL

play06:56

will I see my best DNE and Pace I think

play06:58

that makes more sense sense but what

play07:00

about coronary heart disease risk right

play07:03

if we increase LDL wouldn't that

play07:04

increase heart disease

play07:06

risk so let's take a look at what the

play07:08

data has to show so on the y-axis we've

play07:10

got the hazard ratio for coronary heart

play07:12

disease CHD

play07:14

mortality plotted against serum levels

play07:16

of LDL and there are two main reasons

play07:18

why I like this study first it has a

play07:20

very large sample size this is about 4.5

play07:23

million people that were included in

play07:25

this study and then second is that there

play07:28

are three curves and as we'll see the

play07:30

fully adjusted model included almost

play07:32

every comorbidity that could potentially

play07:34

impact the association for LDL with

play07:37

heart disease risk and unfortunately

play07:38

most studies at least the ones that I've

play07:40

come across don't adjust for all

play07:42

comorbidities that can impact that

play07:44

Association so it's somewhat part of the

play07:47

picture not the full picture whereas I

play07:48

think this study is closer to the full

play07:51

picture and for those who who disagree

play07:54

please leave a comment we can debate

play07:55

that there so in terms of What's

play07:58

significant we put up our red line at a

play08:00

hazard ratio of one remember where the

play08:02

Shaded region for any of these three

play08:04

colored lines is completely above one or

play08:07

completely above below one we have a

play08:09

significant

play08:10

Association so for the first Model Model

play08:13

one this is the minimally adjusted model

play08:14

in blue they adjusted for age sex race

play08:17

and smoking status and just using an LDL

play08:20

of 120 as an example that was

play08:22

significantly associated with a about a

play08:24

20% reduced heart disease mortality risk

play08:28

but then when including stattin use BMI

play08:30

hypertension and diabetes into the model

play08:33

that same 120 for LDL was now only

play08:36

associated with a 10% reduced risk of

play08:38

heart disease mortality risk what about

play08:41

the fully adjusted model so that's shown

play08:43

in green and as I mentioned they

play08:45

adjusted for basically every comorbidity

play08:47

that you can think of in addition to

play08:50

removing data for a 2-year lag so people

play08:52

who died within the first two years was

play08:54

removed so basically these are very sick

play08:57

people who died within 2 years they

play08:58

didn't want that to skew their results

play09:00

and then they also adjusted for HDL

play09:02

pre-existing coronary artery artery

play09:04

disease atrial fibrillation pre-existing

play09:07

heart failure stroke anemia liver

play09:09

disease kidney disease lung disease

play09:11

cancer depression and dementia in other

play09:13

words almost every comorbidity that can

play09:15

impact the association for LDL with

play09:17

heart disease mortality risk and when

play09:20

looking at the data for model 3 now we

play09:22

can see that an LDL of 120 is not

play09:24

significantly associated with a reduced

play09:26

risk for heart disease mortality in

play09:29

contrast when LDL is greater than 120

play09:32

that's associated with a significantly

play09:33

increased heart disease mortality risk

play09:35

but that's only half the story the other

play09:37

half of that story is when LDL was less

play09:40

than 65 Mig per deciliter that too was

play09:43

associated with an increased heart

play09:45

disease mortality risk now if you

play09:47

remember the data on the right hyos

play09:49

nasin reduced my LDL to 65 MGS per

play09:52

deciliter which is right on that edge of

play09:54

an increased heart disease mortality

play09:56

risk so is it possible that in my case

play09:58

for whatever reason Reon going too low

play10:00

for LDL may not be good for epigenetic

play10:03

uh the epigenetic pace of Aging but also

play10:05

potentially bad for heart disease

play10:06

mortality risk at least based on what

play10:08

this published data

play10:10

shows so with that in mind there is a

play10:13

relatively safe range based on this plot

play10:15

for 65 to 120 for LDL being associated

play10:19

with lowest risk for heart disease

play10:20

mortality so I do have room for

play10:22

improvement in my LDL current LDL data

play10:25

to go a bit higher and to do it safely

play10:28

so that in mind that's the goal for the

play10:30

next test to raise LDL to greater than

play10:32

85 Mig per deciliter I'm not talking

play10:34

about anything outrageous like 170 even

play10:37

just a small increase to 90 to 95 to do

play10:40

that I've increased total fat intake

play10:42

which is significantly correlated with

play10:44

LDL in my data those correlations are in

play10:46

the correlation tier on patreon so if

play10:48

you're interested in that check it out

play10:50

but even within total fat where do you

play10:51

go from there so subdividing that

play10:54

saturated fat as expected that's

play10:56

significant correlated with LDL in my

play10:58

data but that doesn't tell you from what

play11:00

also coconut butter is significantly

play11:03

correlated which is the major source of

play11:05

my saturated fat intake so for the next

play11:08

test I've increased coconut butter

play11:10

intake for the past week or so so I'll

play11:12

have about two plus weeks of data with a

play11:14

relatively higher saturated fatty acid

play11:16

content from coconut butter and we'll

play11:18

see if I can push my LDL just a bit

play11:20

higher to test this correlation with the

play11:23

need and Pace will it work test number

play11:25

two in 2024 is scheduled for March 4th

play11:28

so that up video will be coming sometime

play11:30

in April all right that's all for now if

play11:33

you're interested in more about my

play11:34

attempts to biohack aging check us out

play11:36

on patreon and before you go we've got a

play11:37

whole whole bunch of discount links that

play11:39

you may be interested in including

play11:41

discount links for D and pace and

play11:42

epigenetic testing or microbiome

play11:45

composition Ned quantification at home

play11:48

metabolomics at home blood testing with

play11:50

sciox health which includes apob green t

play11:53

diet tracking with chronometer or if

play11:55

you'd like to support the channel you

play11:56

can do that with the website buy me a

play11:57

coffee we've also got merch so if you're

play12:00

interested in wearing the conquer aging

play12:02

or die trying brand as I've got on here

play12:04

that link and all the other links will

play12:06

be in the video's description thanks for

play12:08

watching hope that you enjoyed the video

play12:10

have a great

play12:11

day